ARTL
NASDAQ · Pharmaceuticals
Artelo Biosciences Inc
$5.34
-0.45 (-7.77%)
Open$5.64
Previous Close$5.79
Day High$5.78
Day Low$4.24
52W High$85.80
52W Low$3.15
Volume—
Avg Volume6.07M
Market Cap5.07M
P/E Ratio—
EPS$-39.25
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+194.0% upside
Current
$5.34
$5.34
Target
$15.70
$15.70
$11.87
$15.70 avg
$22.80
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 653.2K | 640.4K | 651.1K |
| Net Income | 176.4K | 175.3K | 172.4K |
| Profit Margin | 27.0% | 27.4% | 26.5% |
| EBITDA | 261.8K | 256.2K | 270.8K |
| Free Cash Flow | 66.8K | 83.8K | 75.0K |
| Rev Growth | -7.3% | -5.3% | +22.2% |
| Debt/Equity | 0.34 | 0.30 | 0.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |